Real-time enrollment status for this non small cell lung cancer (squamous or non squamous) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:03 PM UTC
| NCT Number | NCT07365319 |
| Recruiting Status | Recruiting |
| Condition | Non Small Cell Lung Cancer (Squamous or Non Squamous) |
| Phase | PHASE2 |
| Target Enrollment | 750 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Eikon Therapeutics |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07365319 is currently recruiting participants. This phase2 study for non small cell lung cancer (squamous or non squamous) is actively seeking new participants at 16 locations across the United States. The study is sponsored by Eikon Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07365319 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07365319 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.